findmyKOL

Gerald Gacioch, MD

Basic profile

Rochester General Hospital

ORCIDNone on fileNPI
RegionRochester, NY · NortheastSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Gerald Gacioch is a Cardiology physician affiliated with Rochester General Hospital. OpenAlex indexes 16 publications with 1,036 citations (h-index 7).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
16publications

Distinct works indexed by OpenAlex.

1,036citations

Total citations across indexed works.

7h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

30 Hagen Dr
Suite 100
Rochester, NY 146252658

Telephone

585-338-2700

Provider last certified this registry record 28 Sept 2022.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    79.2%
    Beta blocker20%
    Metoprolol Succinate46%Metoprolol Tartrate25%Carvedilol20%Atenolol6%Labetalol Hcl3%
    Part D<11 patients
    Statin17.4%
    Atorvastatin Calcium62%Rosuvastatin Calcium32%Simvastatin4%Pravastatin Sodium3%
    Part D<11 patients

    + 13 more classes in this area

  • Blood & clotting

    17.5%
    Factor Xa inhibitor9.4%
    Eliquis88%Xarelto12%
    Part D<11 patients
    P2Y12 inhibitor7.2%
    Clopidogrel91%Brilinta9%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    3.3%
    SGLT2 inhibitor2.3%
    Jardiance52%Farxiga48%
    Part D<11 patients
    Potassium supplement1.1%
    Potassium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)83.4% facility · 16.6% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”